Decoding Private Markets: Why access to everything is not access to alpha

by Victor Mayer, Head of International Private Wealth

Private markets have captured the imagination of the wealth community, and evergreen structures are fast becoming the preferred gateway. Single-GP evergreen funds in particular are often marketed as a simple way in: one ticket into a world-class platform with exposure across strategies, asset classes, and geographies, all under the halo of a prestigious brand.

But therein lies the flaw. These funds do not necessarily deliver access to a GP’s best ideas or flagship products. More often, they deliver exposure to the entire platform. And in private markets, where dispersion between strategies and vintages can be wide, that distinction matters.

When investors commit to these vehicles, they are not just buying into a manager’s most proven strategies. They are swept across every sleeve of the platform, from private equity and growth to credit, real estate, infrastructure, secondaries, and sometimes even venture.

On paper this appears as diversification. In practice, it can become indiscriminate exposure, tilted toward the strategies with the greatest capacity rather than those with the greatest edge. The result is often a bundle of platform beta packaged under the guise of alpha.

The myths behind the marketing

This distinction becomes clear when we examine the common myths. Many investors assume that by accessing a GP’s evergreen fund they are securing exposure to the same strategies that built the brand’s reputation. In reality, they are often allocated whatever the firm has capacity to sell. Others believe that such vehicles offer diversification. But concentration risk remains, because exposure is confined to one philosophy, one incentive system, and one franchise.

Even historical outperformance should be considered carefully: leading GPs often built their records through selective flagship funds, not through indiscriminate evergreen wrappers. And while evergreen structures are frequently promoted as efficient, they come with trade-offs, including the loss of control over pacing, fund selection, and manager quality within the machine.

Single-GP vs. Multi-GP: What’s the Difference?

Single-GP evergreen funds deploy across a single sponsor’s own underlying platforms and/or own closed ended funds.

Multi-GP evergreen funds invest across numerous third-party underlying managers and strategies, typically through primaries, secondaries, and co-investments.

What emerges is not alpha capture, but beta packaging. Flagship funds from leading GPs, the crown jewels of private equity, are where discipline, conviction, and alpha tend to reside. Yet single-GP evergreens typically add in strategies far removed from that core.

Credit sleeves can end up functioning more like high-fee fixed income. Real estate platforms may have uneven track records. Infrastructure or secondaries businesses may still be unproven. And evergreen allocations often include new vintages well before any evidence of performance is established.

For investors, this can feel like being forced to buy every mutual fund a manager offers, regardless of quality, but in a less liquid and more expensive structure.

Why selectivity wins in private markets

The alternative is to rethink how core strategies are built. For wealth investors, the case for a multi-GP evergreen approach is compelling. Such vehicles are designed to be selective, not subscribed. By leaning heavily on secondaries and co-investments, they can accelerate deployment, smooth liquidity, and mitigate the risks of cash drag.

By curating only top-performing managers and funds, they avoid the trap of platform loyalty. And by diversifying across vintages, strategies, and philosophies, they create a structure that is more resilient and genuinely focused on extracting alpha.

“A well-built multi-GP evergreen fund with 80%+ secondaries and co-investments, selective access to top-performing funds and managers, vintage and strategy diversification that is loyal only to the best GPs in the market is structurally designed to extract alpha. It’s not about access to a GP. It’s about access to their best work — and to the best work of others. That’s not passive brand exposure. That’s active alpha construction.”

The investor’s choice: shelf or selectivity

Ultimately, the difference is between being allocated into whatever a GP has on the shelf, and curating only the very best of what they (and others) do. For private market investors, that difference is not cosmetic. It defines whether an allocation captures genuine alpha, or merely underwrites brand-driven asset growth.

So when presented with a single-GP evergreen fund as an all-in-one solution, the critical question to ask is simple: are you investing in their edge, or in their entire shelf? Because in private markets, the shelf can get heavy, and no everything on it compounds.

Download this article